Back
to sessions
Sep 28
Science Highlights
SH 06 - Gynecological Cancer - Science Highlights
session DESCRIPTION
The following abstracts will be highlighted in this session:
- 121 — Impact of MMR Status vs. Clinicopathologic Risk Factors on Locoregional Recurrence in Stage I Endometrioid Endometrial Cancer Treated with Brachytherapy Alone — Lara Hathout
- 126 — A Real-World Comparison of Moderated Hypofractionated Radiotherapy and Conventional Fractionated Radiotherapy in Cervical Cancer — Zheng Zeng
- 1039 — Integration of Imaging and Blood-Based Biomarkers for Prognostication in Locally Advanced Cervical Cancer — Shrikiriti Rajan
- 342 — Application of Polyethylene Glycol (PEG) Hydrogel in Radical Concurrent Chemoradiotherapy for Cervical Cancer to Prevent Radiation-Induced Rectal Injury: A Multicenter, Randomized, Parallel-Controlled, Prospective, Phase 3 Trial — Junfang Yan
- 341 — Survival Outcomes of Induction Immunotherapy Combined with Platinum-Based Doublet Chemotherapy Followed by Immunotherapy and Chemoradiotherapy in High-Risk Locally Advanced Cervical Cancer: A Phase II Clinical Trial — Yidi Yuan
Credits
| AMA PRA Category 1 Credits: | 0.50 |
| CAMPEP Credits: | 0.50 |
Presentations
-
08:00am - 08:15am PT
Discussant
Speaker: Lara Hathout, MD, FRCPC - Rutgers Cancer Institute , New Brunswick -
08:15am - 08:30am PT
Discussant
Speaker: Marisa Kollmeier, MD - Memorial Sloan Kettering Cancer Center, New York